Head-to-head · WeighScore
FormBlends vs FuturHealth
The verdict
FormBlends takes it — 72.7/100 to 65.6/100.
FormBlends grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. FormBlends is a US direct-to-consumer brand selling compounded GLP-1 weight-loss medication — compounded semaglutide from $99 and compounded tirzepatide from $349 — dispensed by a licensed 503A pharmacy and…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | FormBlends | FuturHealth |
|---|---|---|
| WeighScore | 72.7/100 | 65.6/100 |
| Grade | C | C |
| Scorecard rank | #75 | #215 |
| Semaglutide | $99/mo (compounded) | $199/mo (compounded) |
| Tirzepatide | $349/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #75 · C
Strengths
- Low published entry price on compounded semaglutide ($99) from a licensed 503A pharmacy
- Physician-supervised program with 24/7 care-team access and free shipping over $150
- Extensive free educational content, guides and provider comparisons on-site
Where it loses points
- Enrollment and final pricing complete on an external portal (rx.formscripts.com), not fully on-site
- $99 may be an intro rate; tirzepatide is comparatively high at $349/mo
- State availability and LegitScript status not published; pharmacy is its own FormScripts brand
Graded #215 · C
Strengths
- LegitScript Certified and HITRUST Certified
- Brand-name and oral GLP-1s on one platform: Wegovy injection and pill, Zepbound, Mounjaro, Ozempic, and Foundayo
- Early direct-to-consumer access to Foundayo (orforglipron), the new oral non-peptide GLP-1
- Bundled registered-dietitian nutrition guidance — uncommon among pure-Rx telehealths
Where it loses points
- Active lawsuit (Wilson v. FuturHealth) alleging unauthorized access to G-Plans subscriber data
- BBB complaints describe recurring charges without medication received — confirm cancellation flow first
- Pharmacy partners described only as 'licensed, U.S.-based' with no specific 503A/503B names
- Pricing not shown until after the qualification questionnaire or portal login
- Front-end brand built on SteadyMD and OpenLoop infrastructure, not a first-party prescriber
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.